Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2015
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 12 Nov 2015 New trial record